-
Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art ...
Introduction Heart failure (HF) is growing to a modern epidemic and despite advances in therapy, it still carries an ominous prognosis and a significant socioeconomic burden.1 Many novel agents that ...
By Maack, Christoph Friday, December 21st 2018
-
Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and ...
Abstract Aim To investigate the characteristics long-term prognostic implications (up to 2.2years) of atrial fibrillation (AF) compared to sinus rhythm (SR), between acute and chronic heart failure ...
By Zafrir, Barak Friday, December 21st 2018
-
Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a ...
Abstract Aims Controversial reports exist in the literature regarding the prognostic role and therapeutic implications of syncope in patients with acute pulmonary embolism (PE). We conducted a ...
By Barco, Stefano Friday, December 14th 2018
Featured Articles
-
Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when ...
This editorial refers to Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials by D.D. Berg et al., on page 3810. ...
By Wallentin, Lars Wednesday, November 7th 2018
-
Cardiovascular Round Table - Industry Partners
The Cardiovascular Round Table comprises 20 industry partners from across the pharmaceuticals, devices and equipment sectors. Abbott Amgen AstraZeneca Bayer Boehringer-Ingelheim Bristol-Myers Squibb ...
Wednesday, October 10th 2018
-
RE-CIRCUIT: uninterrupted anticoagulation with dabigatran to cover left atrial ablation procedures
John Camm is Professor of Clinical Cardiology at St Georges University of London. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac ...
By Camm, A John Monday, October 1st 2018
-
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. ...
Abstract This Consensus Document is the first of two reports summarizing the views of an expert panel organized by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on ...
By Räber, Lorenz Friday, September 14th 2018
-
Have you tried the all-new ESC 365?
ESC Congress 365 is now ESC 365. This all-new platform includes resources from ESC Congress and ESC subspecialty congresses. It features an enhanced, easy-to-use search function so all these ...
Tuesday, August 28th 2018
-
Initiating anticoagulation with the intention of cardioverting: does drug choice matter?
Abstract This editorial refers to Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial by M.D. Ezekowitz et al., on ...
By Mahaffey, Kenneth W Tuesday, August 21st 2018
-
Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCIA ...
Since publication of the 2014 joint consensus document dealing with the management of antithrombotic therapy in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or ...
By Lip, Gregory Y H Tuesday, August 14th 2018
-
Live from ESC Congress 2018
Saturday 25 August Time Session 09:00 - 10:30 Expert Advice - Drug prescription in the elderly 10:30 - 11:00 Interlude 11:00 - 12:30 Expert Advice - Diagnosis and treatment of heart failure with ...
Friday, July 27th 2018
-
Hugo A. Katus MD PhD FESCAfter discovering troponin as a biomarker Katus reached out to genome ...
Known for his work developing a cardiac-specific troponin assay that revolutionized the diagnosis and management of myocardial injury, German cardiologist Hugo Katus has in recent years shifted his ...
By Ozkan, Judy Saturday, July 14th 2018
-
Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of ...
Abstract Aims Harmonized Assessment by Randomized Multicentre Study of OrbusNEichs Combo StEnt (HARMONEE) (NCT02073565) was a randomized pivotal registration trial of the Combo stent, which combined ...
By Saito, Shigeru Saturday, July 7th 2018
Hot Topics
- atrial fibrillation 6
- heart failure 6
- Boehringer Ingelheim 4
- Bristol-Myers Squibb 4
- antiplatelet therapy 4
- coronary artery disease 4
- joint consensus 4
- personal fees 4
- Health Care 3
- dual antiplatelet therapy 3
- european society 3
- inform readers 3
- myocardial infarction 3
- percutaneous coronary intervention 3
- peripheral circulation 3
- preserved ejection fraction 3
- pulmonary circulation 3
- right ventricular function 3
- submitted work 3
- vein thrombosis 3
- European Association 2
- Heart J 2
- Supplementary material 2
- acute coronary syndrome 2
- antagonist oral anticoagulants 2
- antithrombotic therapy 2
- bleeding events 2
- cardiovascular outcomes 2
- clinical characteristics 2
- clinical practice 2
People
- M.L. Neely 10
- Neville Jackson 10
- P. Clemmensen 10
- P.W. Armstrong 10
- Samantha Goldman 10
- Pierre Fabre 9
- Ann Arbor 8
- Luigi Tavazzi 7
- MJ Price 7
- Marie Curie 7
- Merck Sharpe 7
- Gregg W. 6
- Michel Komajda 6
- David Brieger 5
- G. Montalescot 5
- Hoffmann-La Roche 5
- Richard Gallo 5
- Michael Gibson 4
- Nicolas Danchin 4
- A.A. Badar 3
- Abbott Laboratories 3
- Adriaan Potgieter 3
- Alamo Gels 3
- Alan Kerr 3
- Bernard Charbonnel 3
- Clemens Mittman 3
- Cécile Laroche 3
- David Bilheimer 3
- Edwards Lifesciences 3
- Erin Hanley 3